PH17233A - 9-/2-(3-indolyl)ethyl/-1-oxa-4,9-diazaspiro/5,5/undecan-3-ones - Google Patents
9-/2-(3-indolyl)ethyl/-1-oxa-4,9-diazaspiro/5,5/undecan-3-onesInfo
- Publication number
- PH17233A PH17233A PH27035A PH27035A PH17233A PH 17233 A PH17233 A PH 17233A PH 27035 A PH27035 A PH 27035A PH 27035 A PH27035 A PH 27035A PH 17233 A PH17233 A PH 17233A
- Authority
- PH
- Philippines
- Prior art keywords
- carbon atoms
- undecan
- diazaspiro
- oxa
- indolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Photoreceptors In Electrophotography (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/246,459 US4332804A (en) | 1981-03-23 | 1981-03-23 | 9-[2-(3-Indolyl)ethyl]-1oxa-4,9-diazaspiro[5.5]undecan-3-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH17233A true PH17233A (en) | 1984-07-03 |
Family
ID=22930776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH27035A PH17233A (en) | 1981-03-23 | 1982-03-22 | 9-/2-(3-indolyl)ethyl/-1-oxa-4,9-diazaspiro/5,5/undecan-3-ones |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4332804A (de) |
| EP (1) | EP0061333B1 (de) |
| JP (1) | JPS57169485A (de) |
| KR (1) | KR830009094A (de) |
| AT (1) | ATE17249T1 (de) |
| AU (1) | AU557094B2 (de) |
| BR (1) | BR8201589A (de) |
| DE (1) | DE3268225D1 (de) |
| DK (1) | DK129282A (de) |
| ES (1) | ES510649A0 (de) |
| FI (1) | FI820998L (de) |
| IE (1) | IE52652B1 (de) |
| IL (1) | IL65310A (de) |
| NO (1) | NO820937L (de) |
| NZ (1) | NZ200085A (de) |
| PH (1) | PH17233A (de) |
| PL (1) | PL235561A1 (de) |
| PT (1) | PT74626B (de) |
| ZA (1) | ZA821929B (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4861880A (en) * | 1982-09-20 | 1989-08-29 | Pfizer Inc. | 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
| US4879391A (en) * | 1982-09-20 | 1989-11-07 | Pfizer Inc. | 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents |
| US4977178A (en) * | 1982-09-20 | 1990-12-11 | Pfizer Inc. | Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
| GB8808433D0 (en) * | 1988-04-11 | 1988-05-11 | Merck Sharp & Dohme | Therapeutic agents |
| KR20080059687A (ko) * | 2000-03-06 | 2008-06-30 | 아카디아 파마슈티칼스 인코포레이티드 | 세로토닌 관련 질병의 치료에 사용되는 아자시클릭 화합물 |
| WO2003057698A2 (en) * | 2001-12-28 | 2003-07-17 | Acadia Pharmaceuticals, Inc. | Spiroazacyclic compounds as monoamine receptor modulators |
| NZ537522A (en) * | 2002-06-24 | 2006-07-28 | Acadia Pharm Inc | N-substituted piperidine derivatives as serotonin receptor agents |
| US7253186B2 (en) * | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
| US7538222B2 (en) * | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| MXPA05007568A (es) | 2003-01-16 | 2005-09-21 | Acadia Pharm Inc | Agonistas inversos del receptor selectivo de serotonina 2a/2c como terapeuticos para enfermedades neurodegenerativas. |
| US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US7820695B2 (en) * | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
| PL2289879T3 (pl) * | 2004-09-27 | 2015-05-29 | Acadia Pharm Inc | Synteza formy krystalicznej soli winianowej n-(4-fluorobenzylo)-n-(1-metylopiperydyn-4-ylo)-n'-(4-(2-metylopropyloksy)fenylometylo)karbamidu |
| US7790899B2 (en) * | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| WO2008116024A2 (en) | 2007-03-19 | 2008-09-25 | Acadia Pharmaceuticals Inc. | Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
| SI2200610T1 (en) * | 2007-09-21 | 2018-06-29 | Acadia Pharmaceuticals Inc. | Co-administration of pimavanserin with other agents |
| TWI685497B (zh) * | 2014-06-02 | 2020-02-21 | 西班牙商伊史帝夫製藥公司 | 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物 |
| PT3325444T (pt) | 2015-07-20 | 2021-09-22 | Acadia Pharm Inc | Métodos para preparar n-(4-fluorobenzil)-n-(1-metilpiperidina-4-il)-n'-(4-(2-metilpropiloxi)fenilmetil)carbamida e o seu sal de tartarato e forma polimórfica c |
| UA123775C2 (uk) | 2015-11-16 | 2021-06-02 | Естев Фармас'Ютікалз, С.А. | Оксадіазаспіросполуки для лікування зловживання наркотичними засобами та залежності від них |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| WO2018118626A1 (en) | 2016-12-20 | 2018-06-28 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis |
| EP3615028A1 (de) | 2017-04-28 | 2020-03-04 | Acadia Pharmaceuticals Inc. | Pimavanserin zur behandlung von impulskontrollstörungen |
| WO2019046167A1 (en) | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | PIMAVANSERIN FORMULATIONS |
| CN111263764A (zh) | 2017-10-17 | 2020-06-09 | 埃斯蒂文制药股份有限公司 | (r)-9-(2,5-二氟苯乙基)-4-乙基-2-甲基-1-氧杂-4,9-二氮杂螺[5.5]十一烷-3-酮的盐 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3481942A (en) * | 1968-09-06 | 1969-12-02 | Smithkline Corp | Oxa-diazaspiro(4.5)decane compounds |
| US3574204A (en) * | 1969-07-03 | 1971-04-06 | Yoshitomi Pharmaceutical | Piperidine spiro compounds |
| CA952908A (en) * | 1970-02-27 | 1974-08-13 | Yoshitomi Pharmaceutical Industries | Benzodioxane derivatives |
| US3723442A (en) * | 1970-12-31 | 1973-03-27 | Yoshitomi Pharmaceutical | 3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes |
| US4255432A (en) * | 1979-09-06 | 1981-03-10 | Syntex (U.S.A.) Inc. | 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof |
-
1981
- 1981-03-23 US US06/246,459 patent/US4332804A/en not_active Expired - Fee Related
-
1982
- 1982-02-22 BR BR8201589A patent/BR8201589A/pt unknown
- 1982-03-22 IE IE648/82A patent/IE52652B1/en unknown
- 1982-03-22 NO NO820937A patent/NO820937L/no unknown
- 1982-03-22 DK DK129282A patent/DK129282A/da not_active Application Discontinuation
- 1982-03-22 AU AU81769/82A patent/AU557094B2/en not_active Expired - Fee Related
- 1982-03-22 EP EP82301460A patent/EP0061333B1/de not_active Expired
- 1982-03-22 NZ NZ200085A patent/NZ200085A/en unknown
- 1982-03-22 AT AT82301460T patent/ATE17249T1/de not_active IP Right Cessation
- 1982-03-22 DE DE8282301460T patent/DE3268225D1/de not_active Expired
- 1982-03-22 ES ES510649A patent/ES510649A0/es active Granted
- 1982-03-22 PH PH27035A patent/PH17233A/en unknown
- 1982-03-22 PL PL23556182A patent/PL235561A1/xx unknown
- 1982-03-22 IL IL65310A patent/IL65310A/xx unknown
- 1982-03-22 ZA ZA821929A patent/ZA821929B/xx unknown
- 1982-03-22 PT PT74626A patent/PT74626B/pt unknown
- 1982-03-22 KR KR1019820001218A patent/KR830009094A/ko unknown
- 1982-03-22 FI FI820998A patent/FI820998L/fi not_active Application Discontinuation
- 1982-03-23 JP JP57044755A patent/JPS57169485A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ200085A (en) | 1985-07-12 |
| ES8306373A1 (es) | 1983-06-01 |
| AU8176982A (en) | 1982-09-30 |
| PT74626A (en) | 1982-04-01 |
| EP0061333A1 (de) | 1982-09-29 |
| US4332804A (en) | 1982-06-01 |
| JPS57169485A (en) | 1982-10-19 |
| FI820998L (fi) | 1982-09-24 |
| DE3268225D1 (de) | 1986-02-13 |
| IL65310A0 (en) | 1982-05-31 |
| NO820937L (no) | 1982-09-24 |
| IE820648L (en) | 1982-09-23 |
| IE52652B1 (en) | 1988-01-06 |
| BR8201589A (pt) | 1983-02-08 |
| KR830009094A (ko) | 1983-12-17 |
| AU557094B2 (en) | 1986-12-04 |
| PT74626B (en) | 1983-12-19 |
| ZA821929B (en) | 1983-11-30 |
| EP0061333B1 (de) | 1986-01-02 |
| ES510649A0 (es) | 1983-06-01 |
| ATE17249T1 (de) | 1986-01-15 |
| IL65310A (en) | 1985-03-31 |
| DK129282A (da) | 1982-09-24 |
| PL235561A1 (de) | 1982-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH17233A (en) | 9-/2-(3-indolyl)ethyl/-1-oxa-4,9-diazaspiro/5,5/undecan-3-ones | |
| DE3272476D1 (en) | Process for the preparation of indole derivatives, their use as intermediates, and 4-hydroxy indoles | |
| ES486349A1 (es) | Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas | |
| IE820401L (en) | N-£4-(indolyl)-piperidino-alkyl|-benzimidazolines | |
| AU580321B2 (en) | New tryptamine derivatives, a process for their preparation, and their use | |
| GR3004855T3 (de) | ||
| AU4927879A (en) | Derivatives of fluorenes and fluoranthrenes | |
| AU565492B2 (en) | 4-phenyl-4-oxo-buten-2-oic acids | |
| ATE29721T1 (de) | 5-(4-vinyl- oder 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo-(1,2-a -pyrrol-1-carbosaeure und deren derivate. | |
| ES8606847A1 (es) | Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos | |
| TW225989B (de) | ||
| GR79170B (de) | ||
| ES8501762A1 (es) | Procedimiento para preparar nuevos derivados de piperidina | |
| GR3006108T3 (de) | ||
| BE896098A (fr) | Procede de modulation de la reponse immunitaire avec des dibenzocycloheptenylidenes | |
| DE3271277D1 (en) | Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment |